CYANOCOBALAMIN (cyanocobalamin) by Design Pharmaceuticals is 12 can be converted to coenzyme b 12 in tissues, and as such is essential for conversion of methylmalonate to succinate and synthesis of methionine from homocysteine, a reaction which also requires folate. Approved for drug-induced, malabsorption-related vitamin b 12 deficiency not due to pernicious anemia, vitamin b 12 deficiency in adult patients with vitamin b 12 requirements in excess of normal limitations of use and 3 more indications. First approved in 2020.
Drug data last refreshed 21h ago
12 can be converted to coenzyme B 12 in tissues, and as such is essential for conversion of methylmalonate to succinate and synthesis of methionine from homocysteine, a reaction which also requires folate. In the absence of coenzyme B 12 , tetrahydrofolate cannot be regenerated from its inactive…
Vitamin B12
Worked on CYANOCOBALAMIN at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Effect of Methylcobalamin and Cyanocobalamin Consumption on Vitamin B12 Nutritional Status
Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration